Study: Economic gains from meeting physical activity guidelines

San Diego biotech Aven­zo Ther­a­peu­tics has se­cured the ex­clu­sive op­tion to in-li­cense an­oth­er as­set, this time look­ing at glob­al ex-Chi­na rights to a bis­pe­cif­ic in

Patients with advanced estrogen receptor (ER)-positive breast cancer that progressed on CDK4/6 inhibitors had better survival if they continued CDK4/6 inhibition plus endocrine therapy rather